首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1547715

全球血型分型市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Blood Group Typing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球血型鑑定市場的市場規模將從 2023 年的 28.9 億美元達到近 70.1 億美元，2024-2051 年研究期間複合年成長率為 10.33%。

血型分型是確定個人血型的一種方法。這樣做是為了讓人們能夠安全地接受和捐血或輸血。它還可以檢查紅血球表面是否有一種稱為 Rh 因子的物質。它是透過將血液樣本添加到含有與每種抗原相對應的抗體的溶液中來進行的。這是一個快速而簡單的過程，可以在手術期間或受傷後接收或轉移正確類型的血液。

市場動態

透過教育和捐血活動增加捐血實踐以及患者因事故需要血液供應的發生率增加是影響全球血型定型市場成長的重要因素。促進血型分型市場成長的其他因素包括孕婦對血液的需求不斷成長以及法醫研究的不斷增加。血型分型對於檢查與捐贈者血型的兼容性至關重要，這會引發危險的免疫反應。同時，缺乏熟練的專業人員和認知不足可能會導致輸血誤導，導致血型定型市場下降。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球血型分型市場的各個細分市場進行了包容性評估。血型分型產業的成長和趨勢為這項研究提供了一種整體方法。

市場區隔

血型分型市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

耗材
儀器儀表
服務

依技術

基於 PCR 和微陣列技術
基於測定的技術
大規模平行定序技術
其他技術

按測試類型

抗體篩選
HLA分型
交叉匹配測試
ABO 血液檢查
抗原分型

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲血型分型市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。血型分型市場的主要參與者包括 Grifols、SA、Merck KGaA、Bio-Rad Laboratories Inc.、Immucor Inc.、Novacyt Group、Danaher Corporation、Agena Bioscience Inc.、Ortho Clinical Diagnostics、Quotient Ltd。看法，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：血型分型公司的競爭格局

血型分型市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Grifols

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories Inc.

公司概況
公司收入
產品
最新動態

Immucor Inc.

公司概況
公司收入
產品
最新動態

Novacyt Group

公司概況
公司收入
產品
最新動態

Danaher Corporation

公司概況
公司收入
產品
最新動態

Agena Bioscience Inc.

公司概況
公司收入
產品
最新動態

Ortho Clinical Diagnostics

公司概況
公司收入
產品
最新動態

Quotient Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213668

The global demand for Blood Group Typing Market is presumed to reach the market size of nearly USD 7.01 Billion by 2032 from USD 2.89 Billion in 2023 with a CAGR of 10.33% under the study period 2024-2051.

Blood group typing is a method of determining an individual's blood type. It is done so that one can safely receive and donate blood or transfuse. It is also done to check if one has a substance called Rh factor on your red blood cells surface. It is performed by adding a blood sample to a solution containing antibodies corresponding to each antigen. It is a fast and easy process and allows receiving or transferring the right kind of blood during surgery or after an injury.

MARKET DYNAMICS

Rising blood donations practices through education & blood donation campaigns and increasing incidence when patients require blood supply due to accidents are vital factors that influence the global blood group typing market's growth. Other factors contributing to the growth of the blood group typing market are the growing need for blood for pregnant women and rising forensic research. Blood group typing is essential to perform to check compatibility with the donor blood type, triggering a dangerous immune response. Meanwhile, the lack of skilled professionals and inadequate awareness can lead to misleading transfusion, resulting in a decline in the blood group typing market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood Group Typing. The growth and trends of Blood Group Typing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Blood Group Typing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Consumables
Instruments
Services

By Technique

PCR-based and Microarray Techniques
Assay-based Techniques
Massively Parallel Sequencing Techniques
Other Techniques

By Test Type

Antibody Screening
HLA Typing
Cross-matching Tests
ABO Blood Tests
Antigen Typing

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Blood Group Typing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Group Typing market include Grifols, S.A., Merck KGaA, Bio-Rad Laboratories Inc., Immucor Inc., Novacyt Group, Danaher Corporation, Agena Bioscience Inc., Ortho Clinical Diagnostics, Quotient Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BLOOD GROUP TYPING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technique
- 3.7.3 Market Attractiveness Analysis By Test Type
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Consumables Historic and Forecast Sales By Regions
5.5. Instruments Historic and Forecast Sales By Regions
5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY TECHNIQUE

6.1. Overview By Technique
6.2. Historical and Forecast Data
6.3. Analysis By Technique
6.4. PCR-based and Microarray Techniques Historic and Forecast Sales By Regions
6.5. Assay-based Techniques Historic and Forecast Sales By Regions
6.6. Massively Parallel Sequencing Techniques Historic and Forecast Sales By Regions
6.7. Other Techniques Historic and Forecast Sales By Regions

7. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY TEST TYPE

7.1. Overview By Test Type
7.2. Historical and Forecast Data
7.3. Analysis By Test Type
7.4. Antibody Screening Historic and Forecast Sales By Regions
7.5. HLA Typing Historic and Forecast Sales By Regions
7.6. Cross-matching Tests Historic and Forecast Sales By Regions
7.7. ABO Blood Tests Historic and Forecast Sales By Regions
7.8. Antigen Typing Historic and Forecast Sales By Regions

8. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BLOOD GROUP TYPING COMPANIES

9.1. Blood Group Typing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BLOOD GROUP TYPING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Grifols
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. S.A.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Merck KGaA
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Bio-Rad Laboratories Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Immucor Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Novacyt Group
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Danaher Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Agena Bioscience Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Ortho Clinical Diagnostics
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Quotient Ltd
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments